200 related articles for article (PubMed ID: 7166197)
1. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
[No Abstract] [Full Text] [Related]
2. [Immunotherapy of Ehrlich ascites tumor in mice].
Jakóbisiak M
Pol Arch Med Wewn; 1980 May; 63(5):503-9. PubMed ID: 7413475
[No Abstract] [Full Text] [Related]
3. Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
Frenette M; Portelance V; Beaudet R
Microbios; 1983; 36(145-46):173-82. PubMed ID: 6346021
[TBL] [Abstract][Full Text] [Related]
4. [Effect of BCG on the survival of mice following intraperitoneal administration of Ehrlich ascites tumor cells].
Jakóbisiak M; Kossakowska AE; Zelechowska M; Kamiński M
Med Dosw Mikrobiol; 1974; 26(3):235-40. PubMed ID: 4409404
[No Abstract] [Full Text] [Related]
5. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
Tsai TH; Burns RE; Scheving LE
Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of Ehrlich ascites carcinoma (EAC) with antiserum to modified EAC.
Das AK; Roy DK
Indian J Exp Biol; 1985 Nov; 23(11):641-3. PubMed ID: 3833682
[No Abstract] [Full Text] [Related]
7. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
Peeters P; Verloes R; Atassi G; Kanarek L
Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
[No Abstract] [Full Text] [Related]
8. A vaccine and immune serum for ascites tumor of mice and therapy of skin tumors.
Ryu E
Dev Biol Stand; 1977 Apr 13-15; 38():381-5. PubMed ID: 608527
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
10. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
[No Abstract] [Full Text] [Related]
11. The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cells.
Skórski T
Folia Histochem Cytobiol; 1985; 23(1-2):3-10. PubMed ID: 4043437
[TBL] [Abstract][Full Text] [Related]
12. Active immunotherapy in spontaneous leukemia of AkR mice.
Mathé G; Halle-Pannenko O; Bourut C
Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
[No Abstract] [Full Text] [Related]
13. Immunotherapeutic effect of a polyantigenic vaccine in animal tumor models.
Colón JI; Marchand AM; Román Franco AA; Santiago Delpín EA
Bol Asoc Med P R; 1981 Apr; 73(4):162-7. PubMed ID: 6946783
[No Abstract] [Full Text] [Related]
14. [Preventive immunization and immunotherapy of Ehrlich carcinoma and Crocker sarcoma in mice].
Zatula DG
Biull Eksp Biol Med; 1969; 67(1):62-4. PubMed ID: 5404408
[No Abstract] [Full Text] [Related]
15. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
Saha S; Mondal S
J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
[TBL] [Abstract][Full Text] [Related]
16. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
Dobaczewska H
Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
[No Abstract] [Full Text] [Related]
17. Immunostimulating effect of Listeria monocytogenes, BCG and their biologically active extracts on the model of mouse ascites tumors.
Mára M; Nedvĕdová V; Miková Z; Hyncica V
Neoplasma; 1979; 26(6):703-10. PubMed ID: 120515
[No Abstract] [Full Text] [Related]
18. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
Mathé G
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470
[No Abstract] [Full Text] [Related]
19. Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice.
Chedid L; Lamensans A; Parant F; Parant M; Adam A; Petit JF; Lederer E
Cancer Res; 1973 Sep; 33(9):2187-95. PubMed ID: 4725375
[No Abstract] [Full Text] [Related]
20. Effects of BCG (Romanian substrain) on the Ehrlich carcinoma in A2G mice.
Piţur I; Ciufecu E; Drăghici D; Andronescu F; Glăvan D
Arch Roum Pathol Exp Microbiol; 1979; 38(1):95-103. PubMed ID: 546376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
